D. Çabuk

Publishing 2024–2025

Is this you? Claim this profile
3
Articles
622
Reads on Journament
95
Co-authors
2
Journals

This page collects the articles indexed under the name D. Çabuk. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 3

  1. Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.
    clinical breast cancer 2025 255 reads
  2. Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study
    Scientific reports 2025 197 reads
  3. The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study
    Scientific reports 2024 170 reads

Possible papers by D. Çabuk 1

Published under a similar spelling of the name. Beside each paper is the evidence that it may be the same person, strongest first; "Same name only" means there is nothing else to go on.

  1. multifocal extranodal involvement of diffuse large b-cell lymphoma
    as Devrim Cabuk novelty in biomedicine 2013
    Same name only

Under these spellings

Same person? Claim this profile, then add these papers one by one or combine a whole spelling.

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

Also published as

Tick the other spellings that are you. Leave the rest.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Frequent co-authors

Publishes in